Disease measurement - enthesitis, skin, nails, spine and dactylitis

被引:26
作者
Coates, Laura C. [1 ]
Helliwell, Philip S. [1 ]
机构
[1] Univ Leeds, Chapel Allerton Hosp, Acad Sect Musculoskeletal Dis, Leeds Inst Mol Med, Leeds LS7 4SA, W Yorkshire, England
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2010年 / 24卷 / 05期
关键词
spondyloarthropathy; skin; nail; enthesis; dactylitis; outcome measures; clinical assessment; SPONDYLOARTHRITIS RESEARCH CONSORTIUM; INTEROBSERVER RELIABILITY EXERCISE; PSORIASIS SEVERITY INDEX; SHORT-TERM IMPROVEMENT; ANKYLOSING-SPONDYLITIS; CLASSIFICATION CRITERIA; CLINICAL-ASSESSMENT; ARTHRITIS; BATH; VALIDATION;
D O I
10.1016/j.berh.2010.05.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Outcome measurement is a key part of study design but presents particular challenges in spondyloarthropathy Enthesitis and dactylitis are typical features of spondyloarthropathy and validated scoring systems for both are available although the majority of enthesitis outcome measures are validated in ankylosing spondylitis (AS) only Assessment of axial disease is well researched in AS and composite outcome measures are routinely used However assessment of axial disease in predominantly peripheral arthritis such as psoriatic arthritis is problematic and under-researched Extensive research in dermatology has provided multiple outcome measures for skin psoriasis The psoriasis area and severity Index (PASI) remains the most common outcome measure used despite the fact that significant problems exist with this scale and that newer scoring methods and modifications of the PASI show better validity Nail psoriasis is accurately measured by detailed scoring systems but these can be time-consuming (C) 2010 Elsevier Ltd All rights reserved
引用
收藏
页码:659 / 670
页数:12
相关论文
共 50 条
[1]   Interobserver reliability of the Nail Psoriasis Severity Index [J].
Aktan, S. ;
Ilknur, T. ;
Akin, C. ;
Ozkan, S. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) :141-144
[2]  
Anderson JJ, 2001, ARTHRITIS RHEUM-US, V44, P1876, DOI 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO
[3]  
2-F
[4]   PSORIASIS - A MEASURE OF SEVERITY [J].
BAUGHMAN, RD ;
SOBEL, R .
ARCHIVES OF DERMATOLOGY, 1970, 101 (04) :390-&
[5]   Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis [J].
Brandt, J ;
Listing, J ;
Sieper, J ;
Rudwaleit, M ;
van der Heijde, D ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) :1438-1444
[6]   Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Golder, W ;
Gromica-Ihle, E ;
Kellner, H ;
Krause, A ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Thriene, W ;
Sieper, J .
LANCET, 2002, 359 (9313) :1187-1193
[7]  
CALIN A, 1994, J RHEUMATOL, V21, P2281
[8]   Efficacy of acitretin and commercial tanning bed therapy for psoriasis [J].
Carlin, CS ;
Callis, KP ;
Krueger, GG .
ARCHIVES OF DERMATOLOGY, 2003, 139 (04) :436-442
[9]  
Cassell SE, 2007, J RHEUMATOL, V34, P123
[10]  
Chandran V, 2007, J RHEUMATOL, V34, P2463